Loading...
Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice
Schreiber, Karen Frishman, Margreta Russell, Mark D. Dey, Mrinalini Flint, Julia Allen, Alexander Crossley, Amy Gayed, Mary Hodson, Kenneth Khamashta, Munther
Schreiber, Karen
Frishman, Margreta
Russell, Mark D.
Dey, Mrinalini
Flint, Julia
Allen, Alexander
Crossley, Amy
Gayed, Mary
Hodson, Kenneth
Khamashta, Munther
Citations
Altmetric:
Affiliation
South Warwickshire University NHS Foundation Trust; Sandwell and West Birmingham NHS Trust; et al.
Other Contributors
Publication date
2023-04
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Executive Summary of the British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice
Citation
Schreiber K, Frishman M, Russell MD, Dey M, Flint J, Allen A, Crossley A, Gayed M, Hodson K, Khamashta M, Moore L, Panchal S, Piper M, Reid C, Saxby K, Senvar N, Tosounidou S, van de Venne M, Warburton L, Williams D, Yee CS, Gordon C, Giles I; BSR Standards, Audit and Guidelines Working Group. Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice. Rheumatology (Oxford). 2023 Apr 3;62(4):1388-1397. doi: 10.1093/rheumatology/keac559.
Type
Guideline